Alzheimer's precision medicine aims to tailor treatments to the specific genetic, molecular, and clinical characteristics of individuals affected by Alzheimer’s disease and dementia. By leveraging advancements in genetics, biomarkers, and neuroimaging, researchers seek to identify personalized therapies that can effectively slow disease progression or alleviate symptoms based on each patient’s unique profile.
This approach contrasts with traditional one-size-fits-all treatments, recognizing the complex and varied nature of Alzheimer's disease among different individuals. Precision medicine in Alzheimer's holds promise in predicting disease risk, selecting appropriate interventions, and optimizing therapeutic outcomes, ultimately striving towards more targeted and effective care strategies. As research continues to uncover deeper insights into the underlying mechanisms of Alzheimer's, the development and application of precision medicine approaches offer hope for more personalized and impactful treatments in the future.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States